Chemical Properties:
| Item | Specifications |
| Appearance | White or Off-White Powder |
| Purity / Analysis Method | ≥98.0% (HPLC) |
| Impurity ZT-4 | ≤1.0% |
| Enantiomer | ≤0.20% |
| Single Impurity | ≤1.5% |
| Total Impurities | ≤2.0% |
| Test Standard | Enterprise Standard |
| Usage | Ezetimibe (CAS: 163222-33-1) Intermediate |
Description:
Specifications:
Package & Storage:
| Chemical Name | (4S)-3-[(5S)-5-(4-Fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one |
| Synonyms | Ezetimibe Intermediate ZT-5 |
| CAS Number | 189028-95-3 |
| CAT Number | RF-PI146 |
| Stock Status | In Stock, Production Scale Up to Hundreds of Kilograms |
| Molecular Formula | C20H20FNO4 |
| Molecular Weight | 357.38 |
| Brand | Ruifu Chemical |
Advantages:
FAQ:
Application:
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of (4S)-3-[(5S)-5-(4-Fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one (CAS: 189028-95-3) with high quality. It is an intermediate of Ezetimibe (CAS: 163222-33-1) Ezetimibe (CAS: 163222-33-1) is ananti-hyperlipidemic drug used for lowering the plasma cholesterol levels. It is indicated as an adjunctive therapy to diet for the reduction of high-level total-C, LDL-C, and ApoB in patients suffering primary (heterozygous familial and non-familial) hypercholesterolemia. It is also used in combination therapy with HMG-CoA reductase inhibitors.Ezetimibe does not inhibit the cholesterol synthesis in the liver, or increase bile acid excretion.
